DXCM logo

DexCom (DXCM) Shareholders Equity

Annual Shareholders Equity

$2.07 B
-$63.20 M-2.96%

31 December 2023

DXCM Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Shareholders Equity

$1.98 B
-$455.30 M-18.70%

30 September 2024

DXCM Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

DXCM Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-3.0%-12.7%
3 y3 years+13.3%-7.3%
5 y5 years+211.9%+158.9%

DXCM Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-3.0%+13.3%-18.7%+8.5%
5 y5 years-3.0%+211.9%-18.7%+158.9%
alltimeall time-3.0%+4295.1%-18.7%+3721.4%

DexCom Shareholders Equity History

DateAnnualQuarterly
Sept 2024
-
$1.98 B(-18.7%)
June 2024
-
$2.43 B(+8.3%)
Mar 2024
-
$2.25 B(+8.6%)
Dec 2023
$2.07 B(-3.0%)
$2.07 B(-8.8%)
Sept 2023
-
$2.27 B(+8.0%)
June 2023
-
$2.10 B(-5.9%)
Mar 2023
-
$2.23 B(+4.7%)
Dec 2022
$2.13 B(+4.4%)
$2.13 B(+16.8%)
Sept 2022
-
$1.82 B(-19.1%)
June 2022
-
$2.26 B(+3.0%)
Mar 2022
-
$2.19 B(+7.2%)
Dec 2021
$2.04 B(+11.8%)
$2.04 B(-4.4%)
Sept 2021
-
$2.14 B(+6.9%)
June 2021
-
$2.00 B(+5.0%)
Mar 2021
-
$1.90 B(+4.2%)
Dec 2020
$1.83 B(+106.9%)
$1.83 B(+21.8%)
Sept 2020
-
$1.50 B(+10.7%)
June 2020
-
$1.35 B(+44.9%)
Mar 2020
-
$934.50 M(+5.9%)
Dec 2019
$882.60 M(+33.1%)
$882.60 M(+15.5%)
Sept 2019
-
$764.30 M(+11.0%)
June 2019
-
$688.30 M(+2.9%)
Mar 2019
-
$668.60 M(+0.8%)
Dec 2018
$663.30 M(+58.2%)
$663.30 M(+18.0%)
Sept 2018
-
$562.20 M(+16.6%)
June 2018
-
$482.10 M(+14.3%)
Mar 2018
-
$421.70 M(+0.5%)
Dec 2017
$419.40 M(+47.8%)
$419.40 M(+9.2%)
Sept 2017
-
$384.00 M(+8.6%)
June 2017
-
$353.70 M(+27.3%)
Mar 2017
-
$277.80 M(-2.1%)
Dec 2016
$283.80 M(+28.3%)
$283.80 M(+8.4%)
Sept 2016
-
$261.80 M(+6.3%)
June 2016
-
$246.40 M(+6.6%)
Mar 2016
-
$231.20 M(+4.5%)
Dec 2015
$221.20 M(+57.8%)
$221.20 M(+14.4%)
Sept 2015
-
$193.30 M(+13.2%)
June 2015
-
$170.70 M(+14.9%)
Mar 2015
-
$148.60 M(+6.0%)
Dec 2014
$140.20 M
$140.20 M(+21.9%)
Sept 2014
-
$115.00 M(+15.5%)
DateAnnualQuarterly
June 2014
-
$99.60 M(+10.7%)
Mar 2014
-
$90.00 M(+7.0%)
Dec 2013
$84.10 M(+9.2%)
$84.10 M(+12.6%)
Sept 2013
-
$74.70 M(+3.3%)
June 2013
-
$72.30 M(-1.8%)
Mar 2013
-
$73.60 M(-4.4%)
Dec 2012
$77.00 M(-26.3%)
$77.00 M(-4.1%)
Sept 2012
-
$80.25 M(-12.1%)
June 2012
-
$91.31 M(-8.3%)
Mar 2012
-
$99.55 M(-4.7%)
Dec 2011
$104.50 M(+71.3%)
$104.50 M(-7.6%)
Sept 2011
-
$113.06 M(-7.0%)
June 2011
-
$121.58 M(+127.8%)
Mar 2011
-
$53.36 M(-12.5%)
Dec 2010
$60.99 M(-430.7%)
$60.99 M(+73.1%)
Sept 2010
-
$35.24 M(-14.1%)
June 2010
-
$41.02 M(-12.2%)
Mar 2010
-
$46.73 M(-353.3%)
Dec 2009
-$18.45 M(-5.3%)
-$18.45 M(+102.7%)
Sept 2009
-
-$9.10 M(-560.3%)
June 2009
-
$1.98 M(-87.0%)
Mar 2009
-
$15.15 M(-177.8%)
Dec 2008
-$19.47 M(-373.6%)
-$19.47 M(-28.7%)
Sept 2008
-
-$27.29 M(+85.6%)
June 2008
-
-$14.71 M(+408.6%)
Mar 2008
-
-$2.89 M(-140.6%)
Dec 2007
$7.12 M(-87.5%)
$7.12 M(-58.9%)
Sept 2007
-
$17.32 M(-35.1%)
June 2007
-
$26.68 M(-26.7%)
Mar 2007
-
$36.40 M(-35.9%)
Dec 2006
$56.83 M(+15.0%)
$56.83 M(-14.3%)
Sept 2006
-
$66.35 M(-14.9%)
June 2006
-
$78.01 M(+93.7%)
Mar 2006
-
$40.28 M(-18.5%)
Dec 2005
$49.41 M(-200.2%)
$49.41 M(-19.2%)
Sept 2005
-
$61.12 M(-8.9%)
June 2005
-
$67.06 M(-222.7%)
Mar 2005
-
-$54.65 M
Dec 2004
-$49.31 M(+51.3%)
-
Dec 2003
-$32.60 M(+265.1%)
-
Dec 2001
-$8.93 M(+179.8%)
-
Dec 2000
-$3.19 M
-

FAQ

  • What is DexCom annual stockholders equity?
  • What is the all time high annual shareholders equity for DexCom?
  • What is DexCom annual shareholders equity year-on-year change?
  • What is DexCom quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for DexCom?
  • What is DexCom quarterly shareholders equity year-on-year change?

What is DexCom annual stockholders equity?

The current annual shareholders equity of DXCM is $2.07 B

What is the all time high annual shareholders equity for DexCom?

DexCom all-time high annual stockholders equity is $2.13 B

What is DexCom annual shareholders equity year-on-year change?

Over the past year, DXCM annual stockholders equity has changed by -$63.20 M (-2.96%)

What is DexCom quarterly stockholders equity?

The current quarterly shareholders equity of DXCM is $1.98 B

What is the all time high quarterly shareholders equity for DexCom?

DexCom all-time high quarterly stockholders equity is $2.43 B

What is DexCom quarterly shareholders equity year-on-year change?

Over the past year, DXCM quarterly stockholders equity has changed by -$288.90 M (-12.74%)